Rijksinstituut voor Volksgezondheid en Milieu
Effectiveness of Omicron XBB.1.5 vaccine against infection with SARS-CoV-2 Omicron XBB and JN.1 variants, prospective cohort study, the Netherlands, October 2023 to January 2024 | RIVM
Bron:
rivm.nl